Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioProspect Ltd Announces Change Of Chief Executive Officer


Sunday, 18 Nov 2012 06:50pm EST 

BioProspect Ltd announced that Mr. Peter May will contemporaneously cease as Chief Executive Officer, but will continue to provide executive services associated with the Company's biotech assets and projects. He was appointed as a non-executive director, effective November 19, 2012. 

Company Quote

0.0040
0.0010 +33.33%
28 Aug 2014